DIVISLABNSEDivi's Laboratories Limited· PharmaceuticalsMinimalNeutral
Announced Sat, 30 Aug · 16:03 IST

Divi's Laboratories Limited has informed the Exchange about Copy of Newspaper Publication

DIVISLAB · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

Divi's Laboratories has submitted copies of newspaper clippings published on August 30, 2025 in Financial Express and Andhra Prabha, regarding a notice to shareholders for updating their KYC details. The notice outlines the process for physical shareholders to update details using ISR forms (ISR-1, ISR-2, ISR-3/SH-13) via the company's Registrar Kfin Technologies, and for demat holders to update details through their Depository Participants. The notice also references a deadline of November 6, 2025, likely related to the transfer of shares to the Investor Education and Protection Fund (IEPF) Authority for shareholders who have not claimed dividends.

Likely market impact

This is a routine regulatory compliance filing with no material impact on the company's financials or stock price. Shareholders holding physical shares should update their KYC details before the November 6, 2025 deadline to avoid having their shares transferred to the IEPF Authority.